In This Article:
TD SYNNEX (SNX) reported $14.53 billion in revenue for the quarter ended February 2025, representing a year-over-year increase of 4%. EPS of $2.80 for the same period compares to $2.99 a year ago.
The reported revenue compares to the Zacks Consensus Estimate of $14.79 billion, representing a surprise of -1.78%. The company delivered an EPS surprise of -2.44%, with the consensus EPS estimate being $2.87.
While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.
As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.
Here is how TD SYNNEX performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
-
Revenue- Americas: $8.39 billion versus the two-analyst average estimate of $8.39 billion. The reported number represents a year-over-year change of +6.2%.
-
Revenue- Europe: $5.14 billion compared to the $5.40 billion average estimate based on two analysts. The reported number represents a change of +0.4% year over year.
-
Revenue- Asia-Pacific and Japan: $1 billion versus $1.02 billion estimated by two analysts on average. Compared to the year-ago quarter, this number represents a +5.2% change.
View all Key Company Metrics for TD SYNNEX here>>>
Shares of TD SYNNEX have returned -10.2% over the past month versus the Zacks S&P 500 composite's -4% change. The stock currently has a Zacks Rank #4 (Sell), indicating that it could underperform the broader market in the near term.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
TD SYNNEX Corporation (SNX) : Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).